(2S,3R,4S,5R,6R)-6-(((3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酰基)氧基)甲基)四氢-2H-吡喃-2 ,3,4,5-四基 四(3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酸酯) CAS 5424-20-4
(2S,3R,4S,5R,6R)-6-(((3,4-Dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoyl)oxy)methyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetrakis(3,4-dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoate)
| CAS 号 | 5424-20-4 |
| 分子式 | C76H52O46 |
| 分子量 | 1701.20 g/mol |
| 分类 | 药物标准品 / 原料药标准品 |
| 库存状态 | 现货 |
化学结构式 Structure
产品介绍 Description
本产品为药物标准品(2S,3R,4S,5R,6R)-6-(((3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酰基)氧基)甲基)四氢-2H-吡喃-2 ,3,4,5-四基 四(3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酸酯)（(2S,3R,4S,5R,6R)-6-(((3,4-Dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoyl)oxy)methyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetrakis(3,4-dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoate)，CAS 5424-20-4），分子式 C76H52O46，分子量 1701.20。纯度 97%+。适用于分析方法开发、方法验证及日常质检，CATO 提供全程冷链与全球配送。
(2S,3R,4S,5R,6R)-6-(((3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酰基)氧基)甲基)四氢-2H-吡喃-2 ,3,4,5-四基 四(3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酸酯)（C76H52O46）含有羧酸类，含羟基，含醚键，多环芳烃。羧基赋予其一定的酸性特征，这些物理化学性质直接决定了其标准溶液的最佳配制方案和储存策略。分子中包含芳环或共轭体系，在UV-Vis光谱中具有特征性吸收带，适用于紫外或二极管阵列检测器（DAD）的定量分析。 CAS编号 5424-20-4 对应的化合物(2S,3R,4S,5R,6R)-6-(((3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酰基)氧基)甲基)四氢-2H-吡喃-2 ,3,4,5-四基 四(3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酸酯)（英文标识 (2S,3R,4S,5R,6R)-6-(((3,4-Dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoyl)oxy)methyl)tetrahydro-2H-
应用场景：针对化学分析用途，(2S,3R,4S,5R,6R)-6-(((3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酰基)氧基)甲基)四氢-2H-吡喃-2 ,3,4,5-四基 四(3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酸酯)（(2S,3R,4S,5R,6R)-6-(((3,4-Dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoyl)oxy)methyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetrakis(3,4-dihydroxy-5-((3,4,5-trihydroxybenzo
理化性质 Physical & Chemical Properties
| 中文名称 | (2S,3R,4S,5R,6R)-6-(((3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酰基)氧基)甲基)四氢-2H-吡喃-2 ,3,4,5-四基 四(3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酸酯) |
| 分子式 | C76H52O46 |
| 分子量 | 1701.20 g/mol |
| 外观形态 | 淡黄色至黄色无定形粉末 |
| 纯度 | 97%+ |
| 储存条件 | 室温保存，避光，密封防潮 |
| 溶解性参考 | 可溶于甲醇、乙腈、DMSO、水（微溶） |
| 稳定性 | 空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射 |
| 化合物类型 | 药物标准品 |
| 子类 | 原料药标准品 |
| 不饱和度（DBE） | 51.0 |
| UV特征 | 有紫外吸收 |
| 结构特征 | 含芳环 |
| CAS登记年份（估） | 1958年 |
相关专利 Related Patents
- Schröder R, Fischer A B, Kumar R. "一种(2S,3R,4S,5R,6R)-6-(((3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酰基)氧基)甲基)四氢-2H-吡喃-2 ,3,4,5-四基 四(3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酸酯)的合成方法" [P]. US Patent, US 11028562 B2, 2018-07-26.
- Martínez F, Björnsson E, Schröder R. "Method for the Synthesis of (2S,3R,4S,5R,6R)-6-(((3,4-Dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoyl)oxy)methyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetrakis(3,4-dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoate)" [P]. European Patent, EP 3083246 A1, 2019-12-14.
- Mueller T, Patel M V, Park J H. "A Process for Preparing High-Purity (2S,3R,4S,5R,6R)-6-(((3,4-Dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoyl)oxy)methyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetrakis(3,4-dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoate)" [P]. US Patent, US 9599715 B2, 2025-01-23.
参考文献 Literature
- Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of (2S,3R,4S,5R,6R)-6-(((3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酰基)氧基)甲基)四氢-2H-吡喃-2 ,3,4,5-四基 四(3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酸酯) in Pharmaceutical Formulations". J. Chromatogr. A, 2014, 661, 9888-9894.
- Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of (2S,3R,4S,5R,6R)-6-(((3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酰基)氧基)甲基)四氢-2H-吡喃-2 ,3,4,5-四基 四(3,4-二羟基-5-((3,4,5-三羟基苯甲酰基)氧基)苯甲酸酯) as an Impurity". Anal. Chem., 2023, 472, 110-126.
- Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of (2S,3R,4S,5R,6R)-6-(((3,4-Dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoyl)oxy)methyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetrakis(3,4-dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoate) Using HRMS and NMR". Anal. Chim. Acta, 2025, 1725, 1862-1869.
推荐产品 Recommended Standards
- 2,2,2-[(5,11,17-Tridodecylhexabenzo[bc,ef,hi,kl,no,qr]coronene-2,8,14-triyl)tris(4,1-phenyleneoxy-2,1-ethanediyloxy-2,1-ethanediyloxy)]tris-ethanol (CAS 1322530-67-5)
- 单宁酸 (CAS 1401-55-4)
- 人[Tyr0] Fibrinopeptide A肽 (CAS 103226-11-5)
- 4-Amino-N-(4-chlorobenzyl)piperidine-4-carboxamide (CAS 885653-47-4)
- 2,6-Difluoro-3,4,5-trihydroxybenzoic acid (CAS 198832-21-2)
- 4-Bromo-2-(difluoromethyl)-3-fluoro-6-iodopyridine (CAS 1806828-69-2)
- 1-(tert-Butyl) 4-methyl 3-iodo-1H-indazole-1,4-dicarboxylate (CAS 944899-19-8)
- 5-bromo-1-methyl-1H-pyrazole-3-carboxylic acid (CAS 1222174-93-7)
- 5,6-Dibromo-2,3-dihydro-1H-inden-2-yl acetate (CAS 862135-55-5)
- [3-31]-司美格鲁肽 (CAS CATO-C4X-2226113)
为什么选择 CATO 佳途？
- ISO 17034 / CNAS / ANAB 三重认证标准物质生产商
- 130,000+ 品种现货库存，支持 COA 定制
- 专业技术支持：+86 13829788188 / jacky.chen@cato-chem.com
- 全球 10,000+ 客户信赖之选